MRNAModerna, Inc.

Nasdaq modernatx.com


$ 111.83 $ 1.10 (0.99 %)    

Wednesday, 01-May-2024 09:43:05 EDT
QQQ $ 423.24 $ 1.13 (0.27 %)
DIA $ 379.15 $ 0.84 (0.22 %)
SPY $ 501.11 $ 0.29 (0.06 %)
TLT $ 88.54 $ 0.32 (0.36 %)
GLD $ 212.95 $ -0.04 (-0.02 %)
$ 110.31
$ 110.73
$ 0.00 x 0
$ 115.00 x 100
$ 110.66 - $ 112.92
$ 62.55 - $ 142.79
3,172,540
na
42.14B
$ 0.35
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-23-2024 12-31-2023 10-K
2 11-03-2023 09-30-2023 10-Q
3 08-03-2023 06-30-2023 10-Q
4 05-04-2023 03-31-2023 10-Q
5 02-24-2023 12-31-2022 10-K
6 11-03-2022 09-30-2022 10-Q
7 08-03-2022 06-30-2022 10-Q
8 05-04-2022 03-31-2022 10-Q
9 02-25-2022 12-31-2021 10-K
10 11-04-2021 09-30-2021 10-Q
11 08-05-2021 06-30-2021 10-Q
12 05-06-2021 03-31-2021 10-Q
13 02-26-2021 12-31-2020 10-K
14 10-30-2020 09-30-2020 10-Q
15 08-06-2020 06-30-2020 10-Q
16 05-07-2020 03-31-2020 10-Q
17 02-27-2020 12-31-2019 10-K
18 11-06-2019 09-30-2019 10-Q
19 08-08-2019 06-30-2019 10-Q
20 05-09-2019 03-31-2019 10-Q
21 03-13-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 mrna-is-promising-a-breakthrough-in-fighting-cancer

When it comes to cancer, there’s innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a...

 reported-earlier-moderna-out-licenses-covid-19-patents-in-japan-secures-royalty-on-sales-financial-terms-undisclosed

Moderna non-exclusively out-licenses COVID-19-related patents for the territory of Japan Moderna to receive upfront payment ...

 will-earnings-cheer-continue-to-buoy-markets-apple-amazon-pfizer-coinbase-lead-flurry-of-q1-reports-this-week

With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and...

 whats-going-on-with-pfizer-stock-on-thursday

GSK initiates legal proceedings against Pfizer and BioNTech over alleged COVID-19 vaccine patent infringement, intensifying hig...

 moderna-stock-jumps-on-collaboration-with-openai-whats-going-on

Moderna began a collaboration with OpenAI in early 2023 with the launch of Moderna's own instance of ChatGPT, called mChat....

 moderna-and-openai-collaborate-to-advance-mrna-medicine

Generative AI will help advance Moderna's broad and diverse portfolio to maximize the Company's impact on patientsModer...

 moderna-faces-pfizer-biontech-in-london-patent-battle-over-covid-19-vaccines-in-legal-showdown

Moderna challenges Pfizer and BioNTech in a London patent trial over mRNA vaccine patents. The outcome may reshape the pharmace...

 moderna-announced-contract-with-brazils-ministry-of-health-ministrio-da-sade-to-supply-its-mrna-covid-19-vaccine-following-brazilian-health-regulatory-agencys-approval-of-its-updated-covid-19-vaccine-in-march-2024

Under the contract, 12.5 million doses of Moderna's mRNA COVID-19 vaccine are anticipated for delivery in the second quarte...

 johnson--johnson-shows-focus-on-strengthening-its-business-upon-its-consumer-health-unit-spinoff

On Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estima...

 declining-covid-19-vaccine-sales-pinches-moderna-pauses-kenya-vaccine-plant-plans

Moderna pauses plans for Kenya vaccine plant amid declining COVID-19 vaccine demand in Africa. Losses from unfulfilled orders p...

Core News & Articles

https://twitter.com/DrTedros/status/1778423967105139108  

 needham-reiterates-hold-on-moderna

Needham analyst Joseph Stringer reiterates Moderna (NASDAQ:MRNA) with a Hold.

 moderna-paused-construction-of-mrna-vaccine-facility-in-kenya-due-to-declining-covid-19-vaccine-demand-in-africa

Moderna has paused its efforts to build an mRNA manufacturing facility in Kenya while it determines future demand for mRNA vacc...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION